Cargando…

Synthesis and Initial Characterization of a Reversible, Selective (18)F-Labeled Radiotracer for Human Butyrylcholinesterase

PURPOSE: A neuropathological hallmark of Alzheimer’s disease (AD) is the presence of amyloid-β (Aβ) plaques in the brain, which are observed in a significant number of cognitively normal, older adults as well. In AD, butyrylcholinesterase (BChE) becomes associated with A(β) aggregates, making it a p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gentzsch, Christian, Chen, Xinyu, Spatz, Philipp, Košak, Urban, Knez, Damijan, Nose, Naoko, Gobec, Stanislav, Higuchi, Takahiro, Decker, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8277621/ https://www.ncbi.nlm.nih.gov/pubmed/33660167 http://dx.doi.org/10.1007/s11307-021-01584-2

Ejemplares similares

Development of potent reversible selective inhibitors of butyrylcholinesterase as fluorescent probes
por: Pajk, Stane, et al.
Publicado: (2020)

Synthesis and Initial Characterization of a Selective, Pseudo‐irreversible Inhibitor of Human Butyrylcholinesterase as PET Tracer
por: Gentzsch, Christian, et al.
Publicado: (2021)

Development of an in-vivo active reversible butyrylcholinesterase inhibitor
por: Košak, Urban, et al.
Publicado: (2016)

4-Phenethyl-1-Propargylpiperidine-Derived Dual Inhibitors of Butyrylcholinesterase and Monoamine Oxidase B
por: Mazej, Tjaša, et al.
Publicado: (2021)

Initial Evaluation of AF78: a Rationally Designed Fluorine-18-Labelled PET Radiotracer Targeting Norepinephrine Transporter
por: Chen, Xinyu, et al.
Publicado: (2019)

Rationalizing the Binding Modes of PET Radiotracers Targeting the Norepinephrine Transporter
por: Tutov, Anna, et al.
Publicado: (2023)

Treatment of canine cognitive dysfunction with novel butyrylcholinesterase inhibitor
por: Zakošek Pipan, Maja, et al.
Publicado: (2021)

Screening of Big Pharma’s Library against Various in-house Biological Targets
por: Knez, Damijan, et al.
Publicado: (2022)

Subcellular storage and release mode of the novel (18)F-labeled sympathetic nerve PET tracer LMI1195
por: Chen, Xinyu, et al.
Publicado: (2018)

Electrochemical MIP Sensor for Butyrylcholinesterase
por: Ozcelikay, Goksu, et al.
Publicado: (2019)

(18)F-Labeled, PSMA-Targeted Radiotracers: Leveraging the Advantages of Radiofluorination for Prostate Cancer Molecular Imaging
por: Werner, Rudolf A., et al.
Publicado: (2020)

[18F]FDG-labelled stem cell PET imaging in different route of administrations and multiple animal species
por: Nose, Naoko, et al.
Publicado: (2021)

Identification and characterization of the novel reversible and selective cathepsin X inhibitors
por: Fonović, Urša Pečar, et al.
Publicado: (2017)

Ventricular Distribution Pattern of the Novel Sympathetic Nerve PET Radiotracer (18)F-LMI1195 in Rabbit Hearts
por: Werner, Rudolf A., et al.
Publicado: (2019)

Novel (18)F-Labeled PET Imaging Agent FV45 Targeting the Renin–Angiotensin System
por: Chen, Xinyu, et al.
Publicado: (2018)

Recent advances in radiotracers targeting norepinephrine transporter: structural development and radiolabeling improvements
por: Chen, Xinyu, et al.
Publicado: (2020)

Automation of the Radiosynthesis of Six Different (18)F-labeled radiotracers on the AllinOne
por: Li, Shihong, et al.
Publicado: (2016)

The next era of renal radionuclide imaging: novel PET radiotracers
por: Werner, Rudolf A., et al.
Publicado: (2019)

Fragment-Sized Thiazoles in Fragment-Based Drug Discovery Campaigns: Friend or Foe?
por: Proj, Matic, et al.
Publicado: (2022)

A fluorine-18 labeled radiotracer for PET imaging of γ-glutamyltranspeptidase in living subjects
por: Gao, Dingyao, et al.
Publicado: (2021)

Toward Novel [(18)F]Fluorine-Labeled Radiotracers for the Imaging of α-Synuclein Fibrils
por: Uzuegbunam, Bright C., et al.
Publicado: (2022)

Molecular Imaging-Derived Biomarker of Cardiac Nerve Integrity — Introducing High NET Affinity PET Probe (18)F-AF78
por: Chen, Xinyu, et al.
Publicado: (2022)

(61)Cu-Labeled Radiotracers: Alternative or Choice?
por: Fani, Melpomeni, et al.
Publicado: (2023)

Pyrazoles as Key Scaffolds for the Development of Fluorine-18-Labeled Radiotracers for Positron Emission Tomography (PET)
por: Gomes, Pedro M. O., et al.
Publicado: (2020)

Rhenium(i) complexation–dissociation strategy for synthesising fluorine-18 labelled pyridine bidentate radiotracers
por: Klenner, Mitchell A., et al.
Publicado: (2020)

Design, Synthesis, and Biological Evaluation of 2-(Benzylamino-2-Hydroxyalkyl)Isoindoline-1,3-Diones Derivatives as Potential Disease-Modifying Multifunctional Anti-Alzheimer Agents
por: Panek, Dawid, et al.
Publicado: (2018)

N-Hydroxy-N-Propargylamide Derivatives of Ferulic Acid: Inhibitors of Cholinesterases and Monoamine Oxidases
por: Bautista-Aguilera, Óscar M., et al.
Publicado: (2022)

WIDOCK: a reactive docking protocol for virtual screening of covalent inhibitors
por: Scarpino, Andrea, et al.
Publicado: (2021)

Methods to Increase the Metabolic Stability of (18)F-Radiotracers
por: Kuchar, Manuela, et al.
Publicado: (2015)

Reversal of Succinylcholine Induced Apnea with an Organophosphate Scavenging Recombinant Butyrylcholinesterase
por: Geyer, Brian C., et al.
Publicado: (2013)

Novel Radiotracers for Molecular Imaging of Myocardial Inflammation: an Update Focused on Clinical Translation of Non-18F-FDG Radiotracers
por: Shi, Tiantian, et al.
Publicado: (2023)

A new concept for the production of (11)C-labelled radiotracers
por: Wenz, Jan, et al.
Publicado: (2022)

Synthesis, Molecular Modelling and Biological Evaluation of Novel Heterodimeric, Multiple Ligands Targeting Cholinesterases and Amyloid Beta
por: Hebda, Michalina, et al.
Publicado: (2016)

Evaluation of novel cathepsin-X inhibitors in vitro and in vivo and their ability to improve cathepsin-B-directed antitumor therapy
por: Mitrović, Ana, et al.
Publicado: (2022)

Mild, Organo-Catalysed Borono-Deamination as a Key to Late-Stage Pharmaceutical Precursors and (18)F-Labelled Radiotracers
por: Pérez-García, Raúl M., et al.
Publicado: (2022)

Dual-Acting Small Molecules: Subtype-Selective Cannabinoid Receptor 2 Agonist/Butyrylcholinesterase Inhibitor Hybrids Show Neuroprotection in an Alzheimer’s Disease Mouse Model
por: Spatz, Philipp, et al.
Publicado: (2023)

Longitudinal evaluation of a novel BChE PET tracer as an early in vivo biomarker in the brain of a mouse model for Alzheimer disease
por: Rejc, Luka, et al.
Publicado: (2021)

Iodine-131 labeled genistein as a potential radiotracer for breast cancer
por: Ramdhani, Danni, et al.
Publicado: (2020)

Fragment-Sized and Bidentate (Immuno)Proteasome Inhibitors Derived from Cysteine and Threonine Targeting Warheads
por: Kollár, Levente, et al.
Publicado: (2021)

Evaluation of the novel TSPO radiotracer [(18)F] VUIIS1008 in a preclinical model of cerebral ischemia in rats
por: Pulagam, Krishna R., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_giusfimscdvq1ai2sdhc4anp44